Deals
EuroBox Deal Paid Members Public
In Short: Segro PLC, a British logistics real estate giant, is set to acquire Tritax EuroBox in an all-share deal worth £552 million. This transaction offers Segro a broader European logistics portfolio while Tritax shareholders receive a premium on their shares.
Freshfields advises in Ocean Deal Dive Paid Members Public
In Short: Lloyd’s Register is buying a majority stake in Ocean Technologies Group (OTG) from private equity firm Oakley Capital for £50 million. The acquisition will boost Lloyd’s Register’s maritime technology and services portfolio, with a particular focus on training for sustainable maritime practices.
Dickson, Mishcon advise in REIT Takeover Paid Members Public
In Short: U.S. investment firm Starwood Capital is buying British property trust Balanced Commercial Property Trust Ltd. (BCPT) for £674 million, offering shareholders a 21.5% premium. The deal aims to take the REIT private amid a tough real estate market.
Latham & Watkins Guides Microsoft Through CMA Investigation Paid Members Public
In Short: The U.K. Competition and Markets Authority (CMA) has concluded its investigation into Microsoft's hiring of key staff from Inflection AI, finding no significant competition concerns due to the small scale of Inflection's operations.
Baker McKenzie and Linklaters Lead £3.3 Billion Carlsberg-Britvic Acquisition Paid Members Public
In Short: Danish brewer Carlsberg AS is set to acquire Britvic PLC, a UK soft drinks giant, in a £3.3 billion deal, with more than 83% of Britvic’s shareholders approving the takeover. This merger promises to create a formidable force in the British beverage market, combining beer and
BCLP Advises Plus500's $110 Million Share Buyback Paid Members Public
In Short: Israeli fintech Plus500 Ltd. has launched a $110 million share repurchase program to reward investors, signaling strong confidence in its future. The program includes a $35.4 million initial buyback and a $74.6 million special repurchase, with legal guidance from Bryan Cave Leighton Paisner LLP.
Freshfields and Clifford Chance Advise on UCB’s $680 Million Sale Paid Members Public
In Short: Belgian biopharma giant UCB is selling its portfolio of established products in China, including epilepsy drug Keppra and antihistamine Zyrtec, to Singapore's CBC Group and Abu Dhabi’s Mubadala Investment Co. for $680 million. This move allows UCB to focus on developing new medicines in China,
Bird & Bird Advises Capital’s Share Sale Paid Members Public
In Short: Capital Ltd., a UK-based mining services company, sold its entire stake in Predictive Discovery Ltd., an Australian gold explorer, to Perseus Mining for AUD 47.3 million to reduce its debt.
